Allergan's stock dropped 4% Thursday. Photo: Jean-Pierre Clatot / AFP via Getty Images

Allergan "does not intend to make an offer for Shire," the pharmaceutical giant said Thursday.

Driving the news: That's a quick reversal from earlier today, when Reuters reported Allergan was battling Takeda Pharmaceutical to take over Shire.

Go deeper

Felix Salmon, author of Capital
3 mins ago - World

When society faces the unprecedented

Illustration: Aïda Amer/Axios

Our febrile world is not normal.

The big picture: The precautions that we're taking against the spread of COVD-19; the way in which the president of the U.S. delights in violating political norms; the fires, hurricanes and other signs that catastrophic global warming has arrived; the virulent spread of the QAnon conspiracy theory — all of these things, and many more, represent a stunning break with the world as we knew it.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 11 a.m. ET: 34,026,003 — Total deaths: 1,015,107 — Total recoveries: 23,680,268Map.
  2. U.S.: Total confirmed cases as of 11 a.m. ET: 7,237,043 — Total deaths: 207,008 — Total recoveries: 2,840,688 — Total tests: 103,939,667Map.
  3. Health: New poll shows alarming coronavirus vaccine skepticism — New research centers will study "long-haul" COVID — Coronavirus infections rise in 25 states.
  4. Business: Remdesivir is good business for Gilead.
  5. Transportation: The politics of pandemic driving.
  6. 🎧Podcast: The looming second wave of airline layoffs.
Dan Primack, author of Pro Rata
3 hours ago - Economy & Business

The new guinea pig in the Silicon Valley culture war

Illustration: Annelise Capossela/Axios

Coinbase this week offered severance packages to employees who don't feel aligned with the company’s apolitical culture and mission, which CEO Brian Armstrong clarified Sunday in a blog post.

Why it matters: The crypto company, most recently valued by investors at over $8 billion, is setting itself up as a guinea pig in a culture battle that's more about stereotypical Silicon Valley vs. stereotypical Wall Street than it is about progressives vs. libertarians.